| Financial Year |
March 31 2023 |
| Monetary Funds |
729,293,307.86 |
| Held-for-trading Financial Assets |
90,590,263.12 |
| Notes Receivable |
1,730,718.00 |
| Accounts Receivable |
712,375,619.83 |
| Advances to Suppliers |
37,725,841.59 |
| Other Receivables |
49,350,086.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,212,517.77 |
| Dividend Receivable |
498,278.78 |
| Inventories |
336,959,051.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,593,356.37 |
| Total Current Assets |
2,360,721,774.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,422,826,284.92 |
| Investment Properties |
5,759,611.49 |
| Fixed Assetes |
884,961,360.02 |
| Under-construction Projects |
1,111,599,321.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
365,706,833.46 |
| R&D expenses |
-- |
| Goodwill |
437,441,161.33 |
| Long-Term Deferred and Prepaid Expenses |
20,176,811.31 |
| Deferred Income Tax Assets |
41,881,053.46 |
| Other Non-Current Assets |
47,093,586.99 |
| Sub-Total of Non-Current Assets |
4,525,812,833.10 |
| Total Assets |
6,886,534,607.30 |
| Short-Term Loans |
869,386,808.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
188,532,031.47 |
| Accounts Payable |
419,684,162.29 |
| Accounts Received In Advance |
53,333.40 |
| Employee Compensation Payable |
34,493,832.82 |
| Taxes Payable |
31,067,411.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
131,006,002.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
273,177,282.17 |
| Other Current Liabilities |
445,638.78 |
| Sub-Total of Current Liabilities |
1,951,619,878.42 |
| Long-term Loans |
1,011,844,044.43 |
| Bonds Payable |
519,195,200.68 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
53,816,273.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,712,972,788.44 |
| Total Liabilities |
3,664,592,666.86 |
| Paid-In Capital(Or Share Stock) |
596,123,023.00 |
| Capital Surplus |
949,593,384.77 |
| Surplus Reserve |
109,862,697.43 |
| LESS:Treasury Stock |
60,144,281.12 |
| Undistributed Profits |
1,506,851,765.11 |
| Minority Stockholder's Interest |
97,694,268.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,124,247,672.13 |
| Owner's Equity（Stockholder's Equity） |
3,221,941,940.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,886,534,607.30 |
